Hernandez-Beeftink, Tamara
Guillen-Guio, Beatriz
Lorenzo-Salazar, Jose M.
Corrales, Almudena
Suarez-Pajes, Eva
Feng, Rui
Rubio-Rodríguez, Luis A.
Paynton, Megan L.
Cruz, Raquel
García-Laorden, M. Isabel
Prieto-González, Miryam
Rodríguez-Pérez, Aurelio
Carriedo, Demetrio
Blanco, Jesús
Ambrós, Alfonso
González-Higueras, Elena
Espinosa, Elena
Muriel, Arturo
Tamayo, Eduardo
Martin, María M.
Lorente, Leonardo
Domínguez, David
de Lorenzo, Abelardo García
Giannini, Heather M.
Reilly, John P.
Jones, Tiffanie K.
Añón, José M.
Soro, Marina
Carracedo, Ángel
Wain, Louise V.
Meyer, Nuala J.
Villar, Jesús
Flores, Carlos
,
Funding for this research was provided by:
Instituto de Salud Carlos III (CB06/06/1088, PI16/00049, PI17/00610, FI17/00177, PI19/00141, PI20/00876)
Wellcome Trust grant (221680/Z/20/Z)
GSK / Asthma + Lung UK Chair in Respiratory Research (C17-1)
NIH NHLBI awards (HL137006, HL137915, HL155804)
Instituto Tecnológico y de Energías Renovables (OA17/008)
Cabildo Insular de Tenerife (CGIEU0000219140)
Article History
Received: 20 July 2022
Accepted: 17 October 2022
First Online: 5 November 2022
Declarations
:
: The study was approved by the Ethics Committee from the Hospital Universitario de Canarias (Code: CHUNSC_2018-16). All participating studies were done according to The Code of Ethics of the World Medical Association (Declaration of Helsinki), and written informed consent was obtained from all participants or their representatives.
: NJM reports funding to her institution from NIH related to this project; funding to her institution from Quantum Leap Healthcare Collaborative, Biomarck Inc, and Athersys Inc for work unrelated to this manuscript; and participation on the Scientific Advisory Board for Endpoint Health, Inc. She is a member of the Data Safety Monitoring Board for the Careful Ventilation in ARDS (CAVIARDS) trial and the Observational Study Monitoring Board for the SPIROMICS II study. The rest of the authors declare no competing interests.